The Brain Tour, inside dementia is an app designed for iOS and Android phones, that uses augmented reality to transport users inside the brain. Whether you're curious to explore a healthy brain or ...

The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...

The "Brain Computer Interface Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, By Region, ...

Gain’s lead program in Parkinson’s disease has been awarded funding support from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and The Silverstein Foundation for Parkinson’s with GBA, ...

We spend billions searching for the cures to chronic illnesses while neglecting research that could make the daily lives of ...

Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an Investigational Device Exemption ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.

The 3D-printed brain-like model from TU Delft promotes structured neuronal networks, offering a new tool for investigating ...

New research uncovers how declining protein clearance mechanisms with age lead to Alzheimer’s, Parkinson’s, and other ...

Advanced AI genetics models reveal key genetic markers and potential drug repurposing for Parkinson's disease, accelerating the search for new treatments.

An enzyme that helps clear damaged mitochondria can act as a molecular switch and potentially prevent neurons from dying.

Stop the Spread. Injecting saline into mouse kidneys did not affect the left or right substantia nigra (top). Injecting fibrils of α-synuclein ablated about half of the dopaminergic neurons (middle ...